Pulmonx Corp Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pulmonx Corp quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
  • Pulmonx Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$14.1M, a 6.9% increase year-over-year.
  • Pulmonx Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$58.2M, a 7.08% increase year-over-year.
  • Pulmonx Corp annual Operating Income (Loss) for 2023 was -$61.9M, a 5.62% decline from 2022.
  • Pulmonx Corp annual Operating Income (Loss) for 2022 was -$58.6M, a 24% decline from 2021.
  • Pulmonx Corp annual Operating Income (Loss) for 2021 was -$47.3M, a 46.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$58.2M -$14.1M +$1.05M +6.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$59.3M -$15.6M +$817K +4.97% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$60.1M -$14.5M +$1.86M +11.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 -$61.9M -$13.9M +$707K +4.83% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$62.6M -$15.2M -$1.25M -8.94% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 -$61.4M -$16.4M -$2.03M -14.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$59.4M -$16.4M -$732K -4.67% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$58.6M -$14.6M -$2.26M -18.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$56.4M -$13.9M -$4.17M -42.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$52.2M -$14.4M -$1.73M -13.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$50.5M -$15.7M -$3.17M -25.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$47.3M -$12.4M -$3.01M -32.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$44.3M -$9.76M -$4.41M -82.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$39.9M -$12.7M -$1.16M -10% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$38.7M -$12.5M -$6.39M -105% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$32.3M -$9.35M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$5.35M -$1.74M -48% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$11.5M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$6.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 -$3.61M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.